F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to ensure insulin (drug used to lower
blood sugar) was used in accordance with facility ' s manufacturer ' s recommendations and direction for
storage, use, and disposal for two of 14 residents receiving insulin (Residents 4, and 5).
1. Resident 4 insulin was actively in use and available past the manufacturer ' s beyond-use date (BUD- last
date a product can be safely used after it has been altered for resident use).
2. Resident 5 insulin was actively in use and available without an open date.
These failures had the potential for Residents 4, and 5 to receive insulin with reduced potency which could
cause inadequate blood sugar control. These may result in the physician increasing insulin doses based on
the blood sugar results placing the residents at risk for harm.
Findings:
1. An inspection of a medication cart (the Middle Cart), and interview were conducted with a Licensed
Vocational Nurse 2 (LVN 2) on December 19, 2023, at 1:55 PM. An opened 100 units/ milliliter (ml- unit of
measurement) multiple-dose vial of insulin lispro (fast-acting insulin), labeled for Resident 4, was observed
inside the cart. It was labeled with an open date of 11/19/23 (November 19, 2023) indicating the vial was
available for use for 30 days. LVN 2 stated the open date is past 28 days and it should have been changed
on December 17, 2023, two days ago.
During an interview conducted on December 19, 2023, at 2:45 PM with the Director of Nursing (DON), the
DON stated the open date on the insulin vial is passed 28 days and the staff did not follow the facility ' s
policy and procedure (P&P). The DON further stated, and it was important to follow P&P to minimize the
negative effects it would cause the residents.
During a review of the manufacturer ' s recommendations provided by the facility referenced ID: 3273563, .
HUMALOG (insulin lispro injections .). Unopened HUMALOG should be stored in a refrigerator (36 degree
to 46 degrees Fahrenheit [2 degrees to 8 degrees Celsius]) . In-use HUMALOG vials, . should be stored at
room temperature, below 86 degrees Fahrenheit (30 degree Celsius) and must be used within 28 days or
be discarded, even if they still contain HUMALOG .
A review of the facility ' s undated policy and procedure titled Policy and Procedures for Pharmaceutical
Services, indicated, Drugs and biologicals will be stored in a safe, secure and orderly
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
056372
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
056372
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/03/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Brookside Healthcare Center
105 Terracina Blvd.
Redlands, CA 92373
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
fashion, .
Level of Harm - Minimal harm
or potential for actual harm
2. An inspection of a medication cart (the South Cart), and interview were conducted with LVN 3 on
December 19, 2923, at 2:15 PM. An unopened 10 ml multiple-dose vial of insulin Lispro (fast acting insulin)
labeled for Resident 5 was observed incident the cart. It was not labeled with an open date. LVN 3 stated it
should have been in the refrigerator if not open.
Residents Affected - Few
During an interview conducted on December 19, 2023, at 2:45 PM with the DON, the DON stated the open
date on the insulin vial is passed 28 days and the staff did not follow the facility ' s policy and procedure
(P&P). The DON further stated, and it was important to follow P&P to minimize the negative effects it would
cause the residents.
During a review of the manufacturer ' s recommendations provided by the facility referenced ID: 3273563, .
HUMALOG (insulin lispro injections .). Unopened HUMALOG should be stored in a refrigerator (36 degree
to 46 degrees Fahrenheit [2 degrees to 8 degrees Celsius]) . In-use HUMALOG vials, . should be stored at
room temperature, below 86 degrees Fahrenheit (30 degree Celsius) and must be used within 28 days or
be discarded, even if they still contain HUMALOG .
A review of the facility ' s undated policy and procedure titled Policy and Procedures for Pharmaceutical
Services, indicated, Drugs and biologicals will be stored in a safe, secure and orderly fashion, .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
056372
If continuation sheet
Page 2 of 2